Skip to main content

Free Content History of Suborbital Spaceflight: Medical and Performance Issues

Download Article:
(HTML 42.5 kb)
(PDF 657.4 kb)


Campbell MR, Garbino A. History of suborbital spaceflight: medical and performance issues. Aviat Space Environ Med 2011; 82:469–74.

The development of manned sub-orbital commercial space vehicles is rapidly occurring and flight testing followed by operational flights will soon begin. The experience of manned suborbital spaceflight at the designated altitude (100 km/62.14 mi) is very limited—two Mercury-Redstone flights, two X-15 flights, one inadvertent Soyuz launch abort, and three recent SpaceShipOne flights, with only 15 min of critical flight time each. All indications were that the sequence of acceleration-weightlessness-deceleration was well tolerated with minimal neurovestibular dysfunction. However, there are some indications that distraction and spatial disorientation did occur. Vertigo on transition from the boost phase to weightlessness was reported on most high-altitude X-15 flights. +Gz tolerance to re-entry deceleration forces (as high as 6 +Gz) after 4 min of weightlessness is still unknown. Only further suborbital spaceflight experience will clarify if pilot performance will be affected.

Keywords: Gz tolerance; commercial spaceflight; human performance; neurovestibular dysfunction; push-pull effect; vertigo

Document Type: Research Article


Publication date: April 1, 2011

More about this publication?

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more